Included review | Objective/aim | Review type | Countries/regions where the primary studies were conducted | No. of included studies | Participants and sample size | Health topic of the review | Quality assessment of the papers analysed in the review | Data synthesis method of the review |
Egerton et al, 2017.27 | Exploration of the barriers and enablers to implementation of clinical practice guidelines (CPGs) for osteoarthritis management in primary care | SR Qualitative | Australia, France, UK, Germany, Mexico | 8 | Participants: Primary care providers (PCPs) only including general practitioners (GPs), nurses, pharmacists and physical therapists Sample size: 129 | Osteoarthritis | Yes-Critical Appraisal Skills Programme (CASP) checklist | Meta-synthesis |
Ezeani, 2016.28 | Exploration of the barriers and recommendations to implementation of CPGs for asthma management in primary care | SR Qualitative | USA, UK, Canada, Australia, The Netherlands, Sweden, Taiwan, Germany, Saudi Arabia, New Zealand, Singapore | 29 | Participants: Asthma patients, parent caregivers and PCPs including GPs and nurses Sample size: 1846 | Asthma | Yes-Critical Appraisal Skills Programme (CASP) checklist | Thematic analysis |
Mathieson et al, 2018 29 | Exploration of the strategies, barriers and enablers to implementation of evidence-based practice in community nursing | SR Mixed methods | Switzerland, UK, Australia, USA, Canada, Sweden, Belgium, Norway, The Netherlands | 22 | Participants: PCPs without specifying the details Sample size: not specified | Various health topics | Yes-Assessment template for disparate data developed by Hawker et al. (2002)* | Critical Interpretive Synthesis |
Neale et al, 202030 | Exploration of PCPs perceived barriers and enablers to the diagnosis and management of chronic kidney disease in primary care | SR Qualitative | UK, Australia, USA, Canada, The Netherlands | 22 | Participants: PCPs only including GPs, nurses, practice managers, pharmacists and medical assistant Sample size: around 803 | Chronic kidney disease | Yes-Joanna Briggs Institute critical appraisal checklist | Thematic analysis |
Rushforth et al,31 2016 | Exploration of PCPs’ perceived barriers to implementation of CPGs recommended practice for type II diabetes in primary care | SR Qualitative | USA, UK, Europe but non-UK, Asia, Africa, Australia, Oceania | 33† | Participants: PCPs only such as GPs, family medicine specialists, medical offers, government policy makers, nurses Sample size: not specified in some included studies | Type II diabetes | Yes-National Institute for Health and Care Excellence checklist | A framework was used to guide the data analysis |
Slade et al, 201532 | Exploration of PCPs’ perceptions regarding the enablers and barriers of guideline implementation for low back pain management | SR Qualitative | Canada, UK, USA, Germany, New Zealand, Israel, Norway, Ireland, The Netherland | 17 | Participants: PCPs only including GPs, family practitioners, physiotherapists, chiropractors and occupational therapists sample size: 614 | Low back pain | Yes- CASP checklist for qualitative studies | Thematic analysis |
Smeets et al, 201633 | Exploration of PCPs’ perceptions regarding barriers and enablers for managing heart failure patients in primary care | SR Qualitative | UK, Australia, Canada, Uzbekistan | 23 | Participants: GPs Sample size: Not specified | Heart failure | Yes-CASP checklist | Thematic analysis |
Swaithes et al, 202034 | Exploration of the influencing factors for the CPGs implementation in primary care for osteoarthritis management | SR Qualitative | UK, The Netherlands | 4 | Participants: PCPs including GPs and nurses, and patients. Sample size: GPs (n=28), nurses (n=13) and patients (n=46) | Osteoarthritis | Yes-CASP checklist | Thematic analysis |
Tan and Black, 2019 35 | Exploration of the barriers and facilitators to implementation of a guideline for HIV testing | SR Mixed | USA | 12 | Participants: PCPs including GPs, nurses and social workers Sample size: Not specified | HIV testing | Not specified | A framework was used to guide the data analysis |
Unverzagt et al, 201436 | Exploration of the strategies of guideline implementation for cardiovascular diseases in primary care | SR Quantitative | Spain, Canada, UK, USA, Belgium, Sweden, Israel, Taiwan, Pakistan, Germany, Italy, Switzerland, The Netherlands | 54 | Participants: PCPs including physicians, pharmacists or nurses in primary care setting; and patients. Sample size: Physicians (n=8785), patients (n=2 56 550) | Cardiovascular diseases | Yes-Cochrane Collaboration risk of bias tool | Meta-analysis |
Rubio-Valera et al, 2014 37 | Exploration of the barriers and facilitators for the implementation of primary prevention and health promotion (PP and HP) in primary care | SR Qualitative | UK, Denmark, USa, Sweden, Switzerland, Spain, Germany, Israel, Ireland, The Netherlands, Canada, Australia, New Zealand | 35 | Participants: PCPs only, mainly including GPs and nurses Sample size: around 880 | Chronic diseases and health promotion | Yes-A modified checklist for quality appraisal of qualitative studies | Meta-ethnographic |
Wood et al, 201738 | Exploration of the barriers and facilitators to implementing guideline recommendations for depression in primary care | SR Qualitative | UK, USA, Canada, Germany | 18 | Participants: PCPs only such as GPs, primary care psychological therapies Sample size: Not specified | Depression | Yes- CASP checklist for qualitative studies | Thematic analysis |
*Hawker et al. Appraising the evidence: reviewing disparate data systematically. Qualitative health research. 2002 Nov;12(9):1284-99.
†Two of the included articles from one same study.
SR, systematic review.